ArticleThe Journal of antimicrobial chemotherapy2026
Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoring.
Karen F Urbancic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.